Model of β-cell mitochondrial calcium handling and electrical activity. II. Mitochondrial variables

1998 ◽  
Vol 274 (4) ◽  
pp. C1174-C1184 ◽  
Author(s):  
Gerhard Magnus ◽  
Joel Keizer

In the preceding article [ Am. J. Physiol. 274 ( Cell Physiol. 43): C1158–C1173, 1998], we describe the development of a kinetic model for the interaction of mitochondrial Ca2+ handling and electrical activity in the pancreatic β-cell. Here we describe further results of those simulations, focusing on mitochondrial variables, the rate of respiration, and fluxes of metabolic intermediates as a function of d-glucose concentration. Our simulations predict relatively smooth increases of O2consumption, adenine nucleotide transport, oxidative phosphorylation, and ATP production by the tricarboxylic acid cycle asd-glucose concentrations are increased from basal to 20 mM. On the other hand, we find that the active fraction of pyruvate dehydrogenase saturates, due to increases in matrix Ca2+, near the onset of bursting electrical activity and that the NADH/NAD+ ratio in the mitochondria increases by roughly an order of magnitude as glucose concentrations are increased. The mitochondrial ATP/ADP ratio increases by factor of <2 between thed-glucose threshold for bursting and continuous spiking. According to our simulations, relatively small changes in mitochondrial membrane potential (∼1 mV) caused by uptake of Ca2+ are sufficient to alter the cytoplasmic ATP/ADP ratio and influence ATP-sensitive K+ channels in the plasma membrane. In the simulations, these cyclic changes in the mitochondrial membrane potential are due to synchronization of futile cycle of Ca2+ from the cytoplasm through mitochondria via Ca2+ uniporters and Na+/Ca2+exchange. Our simulations predict steady mitochondrial Ca2+concentrations on the order of 0.1 μM at low glucose concentrations that become oscillatory with an amplitude on the order of 0.5 μM during bursting. Abrupt increases in mitochondrial Ca2+concentration >5 μM may occur during continuous electrical activity.

2001 ◽  
Vol 280 (4) ◽  
pp. L779-L791 ◽  
Author(s):  
Shama Ahmad ◽  
Carl W. White ◽  
Ling-Yi Chang ◽  
Barbara K. Schneider ◽  
Corrie B. Allen

Glutamine is an important mitochondrial substrate implicated in the protection of cells from oxidant injury, but the mechanisms of its action are incompletely understood. Human pulmonary epithelial-like (A549) cells were exposed to 95% O2 for 4 days in the absence and presence of glutamine. Cell proliferation in normoxia was dependent on glutamine, and glutamine deprivation markedly accelerated cell death in hyperoxia. Glutamine significantly increased cellular ATP levels in normoxia and prevented the loss of ATP in hyperoxia seen in glutamine-deprived cells. Mitochondrial membrane potential as assessed by flow cytometry with chloromethyltetramethylrosamine was increased by glutamine in hyperoxia-exposed A549 cells, and a glutamine dose-dependent increase in mitochondrial membrane potential was detected. Glutamine-supplemented, hyperoxia-exposed cells had a higher O2 consumption rate and GSH content. Electron and fluorescence microscopy revealed that, in hyperoxia, glutamine protected cellular structures, especially mitochondria, from damage. In hyperoxia, activity of the tricarboxylic acid cycle enzyme α-ketoglutarate dehydrogenase was partially protected by its indirect substrate, glutamine, indicating a mechanism of mitochondrial protection.


Methods ◽  
2008 ◽  
Vol 46 (4) ◽  
pp. 304-311 ◽  
Author(s):  
Werner J.H. Koopman ◽  
Felix Distelmaier ◽  
John J. Esseling ◽  
Jan A.M. Smeitink ◽  
Peter H.G.M. Willems

2001 ◽  
Vol 276 (37) ◽  
pp. 34530-34536 ◽  
Author(s):  
Henrik Kindmark ◽  
Martin Köhler ◽  
Graham Brown ◽  
Robert Bränström ◽  
Olof Larsson ◽  
...  

2016 ◽  
Vol 311 (6) ◽  
pp. C1005-C1013 ◽  
Author(s):  
Julieta Diaz-Juarez ◽  
Jorge Suarez ◽  
Federico Cividini ◽  
Brian T. Scott ◽  
Tanja Diemer ◽  
...  

Diabetic cardiomyopathy is associated with metabolic changes, including decreased glucose oxidation (Gox) and increased fatty acid oxidation (FAox), which result in cardiac energetic deficiency. Diabetic hyperglycemia is a pathophysiological mechanism that triggers multiple maladaptive phenomena. The mitochondrial Ca2+ uniporter (MCU) is the channel responsible for Ca2+ uptake in mitochondria, and free mitochondrial Ca2+ concentration ([Ca2+]m) regulates mitochondrial metabolism. Experiments with cardiac myocytes (CM) exposed to simulated hyperglycemia revealed reduced [Ca2+]m and MCU protein levels. Therefore, we investigated whether returning [Ca2+]m to normal levels in CM by MCU expression could lead to normalization of Gox and FAox with no detrimental effects. Mouse neonatal CM were exposed for 72 h to normal glucose [5.5 mM glucose + 19.5 mM mannitol (NG)], high glucose [25 mM glucose (HG)], or HG + adenoviral MCU expression. Gox and FAox, [Ca2+]m, MCU levels, pyruvate dehydrogenase (PDH) activity, oxidative stress, mitochondrial membrane potential, and apoptosis were assessed. [Ca2+]m and MCU protein levels were reduced after 72 h of HG. Gox was decreased and FAox was increased in HG, PDH activity was decreased, phosphorylated PDH levels were increased, and mitochondrial membrane potential was reduced. MCU expression returned these parameters toward NG levels. Moreover, increased oxidative stress and apoptosis were reduced in HG by MCU expression. We also observed reduced MCU protein levels and [Ca2+]m in hearts from type 1 diabetic mice. Thus we conclude that HG-induced metabolic alterations can be reversed by restoration of MCU levels, resulting in return of [Ca2+]m to normal levels.


Cells ◽  
2019 ◽  
Vol 8 (12) ◽  
pp. 1588 ◽  
Author(s):  
Julia Winter ◽  
Elke Hammer ◽  
Jacqueline Heger ◽  
Heinz-Peter Schultheiss ◽  
Ursula Rauch ◽  
...  

The cardiac-specific overexpression of the adenine nucleotide translocase 1 (ANT1) has cardioprotective effects in various experimental heart disease models. Here, we analyzed the link between ANT1 expression and heat shock protein 27 (HSP27)-mediated toll-like receptor 4 (TLR4) signaling, which represents a novel communication pathway between mitochondria and the extracellular environment. The interaction between ANT1 and HSP27 was identified by co-immunoprecipitation from neonatal rat cardiomyocytes. ANT1 transgenic (ANT1-TG) cardiomyocytes demonstrated elevated HSP27 expression levels. Increased levels of HSP27 were released from the ANT1-TG cardiomyocytes under both normoxic and hypoxic conditions. Extracellular HSP27 stimulated TLR4 signaling via protein kinase B (AKT). The HSP27-mediated activation of the TLR4 pathway was more pronounced in ANT1-TG cardiomyocytes than in wild-type (WT) cardiomyocytes. HSP27-specific antibodies inhibited TLR4 activation and the expression of HSP27. Inhibition of the HSP27-mediated TLR4 signaling pathway with the TLR4 inhibitor oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (OxPAPC) reduced the mitochondrial membrane potential (∆ψm) and increased caspase 3/7 activity, which are both markers for cell stress. Conversely, treating cardiomyocytes with recombinant HSP27 protein stimulated TLR4 signaling, induced HSP27 and ANT1 expression, and stabilized the mitochondrial membrane potential. The activation of HSP27 signaling was verified in ischemic ANT1-TG heart tissue, where it correlated with ANT1 expression and the tightness of the inner mitochondrial membrane. Our study shows a new mechanism by which ANT1 is part of the cardioprotective HSP27-mediated TLR4 signaling.


2016 ◽  
Vol 28 (2) ◽  
pp. 141
Author(s):  
B. R. Mordhorst ◽  
S. L. Murphy ◽  
L. D. Spate ◽  
R. M. Ross ◽  
K. D. Wells ◽  
...  

The morphology (spherical and without cristae) and metabolism (lowly functional) of mitochondria in early embryos and other rapidly proliferating cells exhibit a Warburg effect (WE)-like metabolism. A hallmark of the WE is the predominate use of glycolysis for energy production as opposed to the tricarboxylic acid cycle used by differentiated cells. Additionally, increased signalling of the PI3K pathway is correlated with an increase in glucose metabolism within cancer cells and is consistent with the WE. PS48 stimulates the PI3K pathway, and CPI-613 inhibits pyruvate dehydrogenase. The goal was to achieve a WE-like effect in donor cells before NT. Day 35 porcine fetal fibroblasts were treated as controls (CON, 0 μM) or with CPI (25, 50, or 100 μM) or PS48 (1, 5, 10 μM) for 7 days. Cytometry data were processed using SUMMIT software and analysed via GLM procedure of SAS (SAS Institute Inc., Cary, NC, USA); all variables were analysed for the main effect of drug concentration. Trypan blue cell viability measures were analysed using GLM. For each collection day (i.e. Day 3, 5, and 7), all variables were analysed for the main effect of treatment, duration of culture, and their interaction. All mRNA expression as measured via the ΔΔ-ct method by qPCR was analysed using CT values in GLM for the main effect of drug treatment. Total number of cells and live cells at 120 h was decreased (P ≤ 0.03) in all PS48 treatments compared with CON cells (total cells: CON = 8.95 × 106 v. PS48 treatments ≤6.98 × 106; live cells: CON = 8.39 × 106 v. PS48 treatments ≤6.50 × 106). While the percentage live cells in CPI and CON cells did not differ (P ≥ 0.09), 100 μM decreased the number of total cells and live cells from that of CON for every time point by ~50% (P ≤ 0.02), whereas the other CPI treatments 25 and 50 μM were intermediate. Expression of PDK2 was reduced with 10 μM PS48 treatment compared with CON, and 50 and 100 μM CPI treated cells (P < 0.001; PS48 10 μM: 0.335 v. ≤1.012 other treatments). The CPI 100 μM and 10 μM PS48 concentrations decreased PKM M1 variant expression compared with CON and 50 μM CPI cells (P < 0.001; CPI 100 μM and PS48 10 μM <0.44; CPI 50 μM and CON >0.68). To determine the mitochondrial membrane potential, JC-10 was used. The percentage of cells with high mitochondrial membrane potential decreased (P = 0.04) with PS48 treatment (PS48 treatments ≤19.6%, control = 25.6%). Treatment with CPI also decreased (P ≤ 0.01) membrane potential and the percentages of cells (high function: CPI treatments ≤12.7 v. 25.6% in control; low function: CPI treatments ≥80.3 v. 74.3%). Because PS48 or CPI decrease mitochondrial membrane potential and the abundance of PKM M1, the metabolism of these potential donor cells may be more blastomere like. Experiments are underway to determine whether cells treated with PS48 or CPI will result in better development after somatic cell NT. This study was funded by Food for the 21st Century and NIH R01HD080636.


Author(s):  
Sumera Zaib ◽  
Aqsa Hayyat ◽  
Naba Ali ◽  
Asma Gul ◽  
Muhammad Naveed ◽  
...  

: Apoptosis is a programmed cell death that occurs due to the production of several catabolic enzymes. During this process, several morphological and biochemical changes occur in mitochondria, the main organelle in the cell that participates in apoptosis and control apoptotic pathways. During apoptosis, cytochrome c is released from mitochondria, and different proteins activate caspase cascades that carry out the cell towards the death process. Apoptosis mainly occurs due to p53 protein that allows the abnormal cells to proliferate. Bcl-2 and Bcl-xl are two anti-apoptotic members of the protein family that prevents apoptosis. The membrane potential of mitochondria decreases by opening of the permeability transition pore (PTP). These PTP are formed by the binding of Bax with adenine nucleotide translocator (ANT) and cause depolarization in the membrane. The depolarization releases apoptogenic factors (cytochrome c) that result in the loss of oxidative phosphorylation. Knockdown in lactate dehydrogenase (LDH) is the cause of the decrease in mitochondrial membrane potential elevating the levels of reactive oxygen species (ROS) and Bax. Consequently, causing an increase in the release of cytochrome c that ultimately leads to apoptosis. In this review, we have summarized the combined effect of mitochondrial membrane potential and LDH enzyme that triggers apoptosis in cells and their role in the mechanism of apoptosis.


Sign in / Sign up

Export Citation Format

Share Document